Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Current Pharmaceutical Design|November 15, 2011
Prodrugs in photodynamic anticancer therapyRobert Musiol, Maciej Serda, Jaroslaw Polanski
Oncotarget|May 1, 2018
The role of oxidative stress in activity of anticancer thiosemicarbazonesKatarzyna Malarz, Anna Mrozek-Wilczkiewicz, Maciej Serda, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Iron chelators in photodynamic therapy revisited: synergistic effect by novel highly active thiosemicarbazonesAnna Mrozek-Wilczkiewicz, Maciej Serda, Robert Musiol, et al.
Molecules (Basel, Switzerland)|November 16, 2012
Investigation of the biological properties of (hetero)aromatic thiosemicarbazonesMaciej Serda, Anna Mrozek-Wilczkiewicz, Josef Jampilek, et al.
Journal of Cancer|August 19, 2017
Iron Chelators and Exogenic Photosensitizers. Synergy through Oxidative Stress Gene ExpressionAnna Mrozek-Wilczkiewicz, Katarzyna Malarz, Marzena Rams-Baron, et al.
Bioorganic & Medicinal Chemistry Letters|August 4, 2012
Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacyMaciej Serda, Danuta S Kalinowski, Anna Mrozek-Wilczkiewicz, et al.
European Journal of Medicinal Chemistry|March 29, 2019
Anticancer activity of the thiosemicarbazones that are based on di-2-pyridine ketone and quinoline moietyAnna Mrozek-Wilczkiewicz, Katarzyna Malarz, Marta Rejmund, et al.
Journal of Chemical Information and Modeling|October 3, 2015
Ligand-Based Virtual Screening in a Search for Novel Anti-HIV-1 ChemotypesAgata Kurczyk, Dawid Warszycki, Robert Musiol, et al.
Bioorganic & Medicinal Chemistry|February 15, 2011
X-ray and molecular modelling in fragment-based design of three small quinoline scaffolds for HIV integrase inhibitorsKatarzyna Majerz-Maniecka, Robert Musiol, Agnieszka Skórska-Stania, et al.
Pageof 13